- Home
- WPC vs RVMD Comparison
WPC vs RVMD Comparison
Compare WPC & RVMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | WPC | RVMD |
|---|---|---|
| Founded | 1973 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 14.3B | 15.2B |
| IPO Year | 1998 | 2020 |
Fundamental Metrics
Financial Performance| Metric | WPC | RVMD |
|---|---|---|
| Price | $64.86 | $80.73 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 10 | 17 |
| Target Price | ★ $108.11 | $77.47 |
| AVG Volume (30 Days) | 1.3M | ★ 2.4M |
| Earning Date | 02-10-2026 | 11-05-2025 |
| Dividend Yield | ★ 5.68% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.65 | N/A |
| Revenue | ★ $1,670,291,000.00 | N/A |
| Revenue This Year | $7.71 | N/A |
| Revenue Next Year | $5.12 | $714.50 |
| P/E Ratio | $39.27 | ★ N/A |
| Revenue Growth | ★ 5.29 | N/A |
| 52 Week Low | $52.91 | $29.17 |
| 52 Week High | $69.79 | $81.97 |
Technical Indicators
Market Signals| Indicator | WPC | RVMD |
|---|---|---|
| Relative Strength Index (RSI) | 43.53 | 67.25 |
| Support Level | $63.85 | $74.20 |
| Resistance Level | $65.51 | $81.97 |
| Average True Range (ATR) | 0.96 | 2.50 |
| MACD | -0.05 | -0.44 |
| Stochastic Oscillator | 38.87 | 84.78 |
Price Performance
Historical ComparisonAbout WPC W. P. Carey Inc. REIT
W.P. Carey Inc is a real estate investment trust principally involved in the ownership of properties located in the U.S., Western Europe, and Northern Europe. W.P. Carey organizes its operations into Real Estate and Investment Management segments. The vast majority of the company's income is derived from its Real Estate division in the form of lease revenue from long-term agreements with companies. W.P. Carey's real estate portfolio is primarily comprised of single-tenant office, industrial, warehouse, and retail facilities located around the world. majority of the company's revenue comes from properties in the USA. Its Investment Management unit generates revenue from providing real estate advisory and portfolio management services to other REITs.
About RVMD Revolution Medicines Inc.
Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products includes RMC-4630, a SHP2 inhibitor, RAS(ON) portfolio and SOS1 and 4EBP1/mTORC1 programs.